Corvus Pharmaceuticals (CRVS) Institutional Ownership $8.19 -0.33 (-3.87%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)CurrentInstitutional OwnershipPercentage46.64%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$20.10MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$5.66M Get CRVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRVS Institutional Buying and Selling by Quarter Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Corvus Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC563,009$2.97M0.0%+22.4%0.900% 11/15/2024 XTX Topco Ltd14,086$74K0.0%N/A0.023% 11/15/2024Jane Street Group LLC50,221$265K0.0%N/A0.080% 11/15/2024 State Street Corp178,246$941K0.0%+48.2%0.285% 11/15/2024 Point72 Asset Management L.P.5,562,729$29.37M0.1%-6.7%8.893% 11/12/2024 Nwam LLC10,050$53K0.0%N/A0.016% Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/8/2024 Connor Clark & Lunn Investment Management Ltd.137,031$724K0.0%+64.7%0.219% 11/6/2024 OneDigital Investment Advisors LLC10,000$53K0.0%-31.3%0.016% 11/6/2024 Towerview LLC117,500$620K0.4%-70.6%0.188% 11/6/2024 Oppenheimer & Co. Inc.16,947$89K0.0%N/A0.027% 10/10/2024 Avity Investment Management Inc.27,580$146K0.0%+138.2%0.044% 9/16/2024 Cubist Systematic Strategies LLC24,364$44K0.0%N/A0.039% 8/19/2024 Point72 Asset Management L.P.5,964,510$10.86M0.0%N/A9.535% 8/14/2024 Cubist Systematic Strategies LLC24,364$44K0.0%N/A0.039% 8/14/2024 Marshall Wace LLP74,559$136K0.0%N/A0.119% 8/14/2024 Samlyn Capital LLC6,123,021$11.14M0.2%+160.7%9.789% 8/9/2024 Renaissance Technologies LLC563,932$1.03M0.0%-11.5%0.902% 7/26/2024 Towerview LLC400,000$728K0.5%+4.6%0.639% 5/16/2024 BVF Inc. IL361,406$643K0.0%-73.6%0.737% 5/10/2024 Vanguard Group Inc.1,493,357$2.66M0.0%+10.6%3.045% 5/7/2024 Towerview LLC382,500$681K0.5%-12.4%0.780% 2/1/2024 Towerview LLC436,873$769K0.5%+27.6%0.891% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.70,883$103K0.0%-16.0%0.145% 11/4/2023 Towerview LLC342,478$500K0.3%+67.1%0.699% 9/8/2023Tucker Asset Management LLC12,871$29K0.0%N/A0.026% 8/22/2023CHI Advisors LLC200,000$458K0.1%-91.5%0.408% 8/11/2023 MYDA Advisors LLC100,000$229K0.1%N/A0.204% 8/7/2023 Acadian Asset Management LLC58,069$132K0.0%-55.9%0.125% 8/3/2023 Towerview LLC205,000$469K0.3%N/A0.440% 7/27/2023Virtu Financial LLC25,542$58K0.0%+32.0%0.055% 5/11/2023CHI Advisors LLC2,339,402$2.13M0.6%-1.9%5.024% 2/14/2023 Discovery Capital Management LLC CT548,727$466K0.1%N/A1.179% 11/17/2022Telemetry Investments L.L.C.522,009$427K0.5%+13.5%1.121% 10/18/2022 Bailard Inc.39,998$33K0.0%N/A0.086% 4/20/2022 Jackson Square Capital LLC63,773$105K0.0%N/A0.137% 4/13/2022 Hikari Power Ltd49,959$82K0.0%+150.3%0.107% 2/15/2022 Coastal Bridge Advisors LLC24,000$58K0.0%N/A0.052% 2/14/2022 Point72 Asset Management L.P.795,000$1.92M0.0%+38.3%1.708% 2/10/2022 Acadian Asset Management LLC81,166$194K0.0%+96.9%0.174% 11/22/2021 EcoR1 Capital LLC2,081,077$10.07M0.4%-41.9%4.471% Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide11/16/2021 Squarepoint Ops LLC19,954$97K0.0%N/A0.043% 11/16/2021 Tang Capital Management LLC3,749,379$18.15M3.8%N/A8.055% 11/16/2021 Two Sigma Investments LP140,455$680K0.0%-54.6%0.302% 11/16/2021 Two Sigma Securities LLC22,789$110K0.0%N/A0.049% 11/16/2021Telemetry Investments L.L.C.196,168$949K1.3%-25.7%0.421% 11/16/2021 VR Adviser LLC3,427,461$16.59M2.1%N/A7.363% 11/16/2021 BVF Inc. IL1,370,947$6.64M0.3%-62.7%2.945% 11/16/2021CHI Advisors LLC165,927$803K0.2%-76.9%0.356% 11/15/2021 Point72 Asset Management L.P.575,000$2.78M0.0%N/A1.235% 11/15/2021 Pura Vida Investments LLC734,268$3.55M0.1%N/A1.577% 11/15/2021 Zacks Investment Management10,000$48K0.0%N/A0.021% 11/12/2021 Affinity Asset Advisors LLC50,000$242K0.1%N/A0.107% 11/12/2021 Renaissance Technologies LLC614,370$2.97M0.0%-6.6%1.320% 11/12/2021 DC Investments Management LLC50,709$245K0.5%N/A0.109% 11/12/2021 MYDA Advisors LLC60,000$290K0.1%N/A0.129% 11/12/2021 Geode Capital Management LLC210,243$1.02M0.0%+10.9%0.452% 11/12/2021 Artal Group S.A.500,000$2.42M0.1%N/A1.074% 11/9/2021BlackRock Inc.100,451$486K0.0%-23.3%0.216% 11/5/2021 Lindbrook Capital LLC14,000$68K0.0%N/A0.033% 8/17/2021 BVF Inc. IL3,678,626$9.82M0.4%+13.9%8.672% 8/16/2021Telemetry Investments L.L.C.263,975$705K1.0%+6.0%0.622% 8/16/2021 State Street Corp29,600$79K0.0%N/A0.070% 8/13/2021 Renaissance Technologies LLC658,070$1.76M0.0%-0.8%1.551% 8/13/2021 Northern Trust Corp59,262$158K0.0%+56.5%0.140% 8/13/2021 Laurion Capital Management LP59,150$158K0.0%-79.0%0.139% 8/13/2021 Algert Global LLC19,737$53K0.0%-53.9%0.047% 8/13/2021 Natixis27,900$74K0.0%+69.1%0.066% 8/13/2021 Geode Capital Management LLC189,541$506K0.0%+27.4%0.447% 8/13/2021 Vanguard Group Inc.1,109,218$2.96M0.0%+10.9%2.615% 8/12/2021 Dimensional Fund Advisors LP395,829$1.06M0.0%-5.0%0.933% 8/11/2021CHI Advisors LLC719,132$1.92M0.4%+5.9%1.695% 5/18/2021 BVF Inc. IL3,229,426$9.95M0.4%+66.1%8.430% 5/18/2021 Millennium Management LLC99,096$305K0.0%-18.5%0.259% 5/18/2021 Orbimed Advisors LLC8,053,298$24.80M0.2%+19.0%21.021% 5/17/2021 Ikarian Capital LLC100,000$307K0.0%N/A0.261% 5/17/2021 Goldman Sachs Group Inc.30,804$95K0.0%-62.3%0.080% 5/14/2021 Laurion Capital Management LP282,132$869K0.0%N/A0.736% 5/14/2021 Dimensional Fund Advisors LP416,649$1.28M0.0%-4.5%1.088% 5/14/2021 Algert Global LLC42,857$132K0.0%+177.1%0.112% 5/13/2021 Renaissance Technologies LLC663,470$2.04M0.0%-16.8%1.732% 5/12/2021 Northern Trust Corp37,878$116K0.0%+28.6%0.099% 5/12/2021 Geode Capital Management LLC148,834$458K0.0%+34.5%0.388% 5/11/2021 Mercer Global Advisors Inc. ADV10,500$32K0.0%N/A0.027% 5/11/2021 Acadian Asset Management LLC20,936$64K0.0%-77.4%0.055% 5/10/2021 GSA Capital Partners LLP95,613$294K0.0%N/A0.250% 5/10/2021 Bank Julius Baer & Co. Ltd Zurich336,748$1.04M0.0%N/A0.879% 5/7/2021BlackRock Inc.77,668$239K0.0%+11.3%0.203% 5/4/2021 Envestnet Asset Management Inc.10,500$32K0.0%N/A0.027% 2/18/2021 Truist Financial Corp21,000$75K0.0%N/A0.075% 2/12/2021CHI Advisors LLC490,877$1.75M0.5%-15.8%1.749% Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide2/10/2021 Renaissance Technologies LLC797,070$2.84M0.0%-8.9%2.840% 2/5/2021BlackRock Inc.69,810$248K0.0%-56.8%0.249% 1/25/2021Golden Green Inc.19,539$70K0.1%N/A0.070% 11/13/2020 Morgan Stanley32,746$131K0.0%+117.7%0.117% 11/9/2020 Acadian Asset Management LLC157,134$630K0.0%-13.5%0.560% 11/6/2020BlackRock Inc.161,549$647K0.0%-48.0%0.576% (Data available from 1/1/2016 forward) CRVS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRVS shares? During the previous two years, 24 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Point72 Asset Management L.P. ($29.37M), Samlyn Capital LLC ($11.14M), Geode Capital Management LLC ($2.97M), Vanguard Group Inc. ($2.66M), Renaissance Technologies LLC ($1.03M), State Street Corp ($941K), and Connor Clark & Lunn Investment Management Ltd. ($724K).Learn more on CRVS's institutional investors. What percentage of Corvus Pharmaceuticals stock is owned by institutional investors? 46.64% of Corvus Pharmaceuticals stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings. Which institutional investors have been buying Corvus Pharmaceuticals stock? Of the 19 institutional investors that purchased Corvus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($5.96M), Samlyn Capital LLC ($3.77M), Discovery Capital Management LLC CT ($548.73K), Towerview LLC ($454.37K), Vanguard Group Inc. ($142.72K), Geode Capital Management LLC ($102.87K), and MYDA Advisors LLC ($100K). How much institutional buying is happening at Corvus Pharmaceuticals? Institutional investors have bought a total of 11,511,169 shares in the last 24 months. This purchase volume represents approximately $21.56M in transactions. Which Corvus Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Corvus Pharmaceuticals stock in the last 24 months: CHI Advisors LLC ($2.18M), BVF Inc. IL ($1.01M), Point72 Asset Management L.P. ($401.78K), Towerview LLC ($336.87K), Acadian Asset Management LLC ($73.70K), Renaissance Technologies LLC ($73.10K), and Connor Clark & Lunn Investment Management Ltd. ($13.49K). How much institutional selling is happening at Corvus Pharmaceuticals? Institutional investors have sold a total of 4,097,434 shares in the last 24 months. This volume of shares sold represents approximately $10.79M in transactions. Related Companies Immunome Major Shareholders Enlivex Therapeutics Major Shareholders Aytu BioPharma Major Shareholders Scholar Rock Major Shareholders Recursion Pharmaceuticals Major Shareholders Mirum Pharmaceuticals Major Shareholders Harmony Biosciences Major Shareholders Wave Life Sciences Major Shareholders Centessa Pharmaceuticals Major Shareholders Nurix Therapeutics Major Shareholders This page (NASDAQ:CRVS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
